[{"data":1,"prerenderedAt":172},["ShallowReactive",2],{"drug-liothyronine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":54,"contraindications":78,"warnings":88,"renal":96,"monitoring":97,"interactions":98,"review":99,"examples":102,"atc":108,"iran":110,"links":117,"populations":133,"usApproval":167},"liothyronine",1,{"fa":7,"en":8},"لیوتیرونین (T3)","Liothyronine (T3)","systemic-hormones",{"fa":11,"en":12},"هورمون تیروئید","Thyroid hormone",[14],{"name":15,"market":16},"Cytomel","US",[18,19,20,21],"cytomel","T3","لیوتیرونین","تری یدوتیرونین",[23,37,46],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":32,"refs":33},"tab-5","tablet","oral","5 mcg tablet",{"amount":29,"unit":30,"perUnit":25,"scored":31},5,"mcg",false,[16],[34],{"source":35,"section":36},"fda-liothyronine","3",{"id":38,"form":25,"route":26,"label":39,"concentration":40,"markets":43,"refs":44},"tab-25","25 mcg tablet (scored)",{"amount":41,"unit":30,"perUnit":25,"scored":42},25,true,[16],[45],{"source":35,"section":36},{"id":47,"form":25,"route":26,"label":48,"concentration":49,"markets":51,"refs":52},"tab-50","50 mcg tablet (scored)",{"amount":50,"unit":30,"perUnit":25,"scored":42},50,[16],[53],{"source":35,"section":36},[55],{"id":56,"disease":57,"label":58,"population":61,"type":65,"unit":30,"dose":66,"refs":68,"notes":71},"hypo","hypothyroidism",{"fa":59,"en":60},"کم‌کاری تیروئید — شروع ۲۵ mcg روزانه؛ نگهدارنده معمولاً ۲۵ تا ۷۵ mcg","Hypothyroidism — start 25 mcg daily; usual maintenance 25–75 mcg",{"minAge":62},{"value":63,"unit":64},18,"year","fixed",{"perDose":41,"perDoseMax":67,"dosesPerDay":5},75,[69],{"source":35,"section":70},"2.2",[72],{"text":73,"refs":76},{"fa":74,"en":75},"افزایش ۲۵ mcg هر ۱ تا ۲ هفته بر اساس TSH. سالمند یا بیمار قلبی: شروع ۵ mcg.","Increase by 25 mcg every 1–2 weeks by TSH. Elderly or cardiac patients: start 5 mcg.",[77],{"source":35,"section":70},[79],{"id":80,"severity":81,"text":82,"refs":85},"adrenal","block",{"fa":83,"en":84},"نارسایی آدرنال اصلاح‌نشده.","Uncorrected adrenal insufficiency.",[86],{"source":35,"section":87},"4",[89],{"text":90,"refs":93},{"fa":91,"en":92},"هشدار جعبه‌ای: برای چاقی یا کاهش وزن نه؛ دوز بالا سمیت جدی یا کشنده دارد.","Boxed warning: not for obesity or weight loss; large doses can cause serious or life-threatening toxicity.",[94],{"source":35,"section":95},"Boxed Warning",[],[],[],{"status":100,"reviewer":101,"date":101},"unverified",null,[103],{"regimen":56,"formulation":38,"input":104,"expect":107},{"ageYears":105,"weightKg":106},45,70,{"perDose":41,"tabletsPerDoseRounded":5,"upperPerDose":67},[109],"H03AA02",{"status":111,"refs":112},"not-found",[113],{"source":114,"section":115,"url":116},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Liothyronine",[118,122,126,130],{"kind":119,"url":120,"label":121},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=211510","ANDA211510",{"kind":123,"url":124,"label":125},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=548d684a-86f5-4e57-9844-d8cf0a84e068","FDA Liothyronine",{"kind":127,"url":128,"label":129},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682462.html","Liothyronine",{"kind":131,"url":132,"label":109},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=H03AA02",{"pregnancy":134,"lactation":143,"pediatric":151,"geriatric":159},{"level":135,"text":136,"quote":139,"refs":140},"caution",{"fa":137,"en":138},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Experience with liothyronine use in pregnant women, including data from post-marketing studies, have not reported increased rates of major birth defects or miscarriages (see Data).",[141],{"source":35,"section":142},"8.1",{"level":135,"text":144,"quote":147,"refs":148},{"fa":145,"en":146},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary Limited published studies report that liothyronine is present in human milk.",[149],{"source":35,"section":150},"8.2",{"level":135,"text":152,"quote":155,"refs":156},{"fa":153,"en":154},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The initial dose of liothyronine sodium tablets varies with age and body weight.",[157],{"source":35,"section":158},"8.4",{"level":135,"text":160,"quote":163,"refs":164},{"fa":161,"en":162},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","… ronine sodium tablets at less than the full replacement dose [see Dosage and Administration ( 2.3 ) and Warnings and Precautions ( 5.1 )] .",[165],{"source":35,"section":166},"8.5",{"kind":168,"refs":169,"id":121},"ANDA",[170],{"source":35,"section":171},"SPL approval \u002F marketing category",1792156184898]